Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled recombinant human interferon alpha-1b for viral pneumonia in children
ChiCTR-TRC-13003065Phase 4Completed
- Sponsor
- Guangzhou Women and Children’s Medical Center
- Start
- Mar 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human interferon alpha-1b in viral pneumonia (2 arms), sponsored by Guangzhou Women and Children’s Medical Center. Primary endpoints: Cure rate, Average hospital time and 1 more. Started Mar 2013; status: completed.
02
Drugs
recombinant human interferon alpha-1b
03
Conditions
viral pneumonia
Beyond the preview
Go deeper on ChiCTR-TRC-13003065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003065.